Microscopic colitis and colorectal neoplastic lesion rate in chronic nonbloody diarrhea: A prospective, multicenter study

Inflammatory Bowel Diseases

Volumn 20, Issue 5, 2014, Pages 882-891

  Tontini, Gian Eugenio ^a,b   Pastorelli, Luca ^a,c   Spina, Luisa ^a   Fabris, Federica ^d   Bruni, Barbara ^a   Clemente, Claudio ^a   De Nucci, Germana ^a   Cavallaro, Flaminia ^a   Marconi, Stefano ^e   Neurath, Markus F ^b   Neumann, Helmut ^b   Tacconi, Milena ^d   Vecchi, Maurizio ^a,c  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF MILAN   (Italy)

^d Gastroenterology and Digestive Endoscopy Unit Istituti Clinici Zucchi   (Italy)

^e CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

Chronic nonbloody diarrhea; Collagenous colitis; Colonoscopy; Colorectal cancer; Microscopic colitis

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY; CHRONIC NONBLOODY DIARRHEA; COLLAGENOUS COLITIS; COLONOSCOPY; COLORECTAL TUMOR; CONTROLLED STUDY; DIARRHEA; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC COLITIS; MIDDLE AGED; MULTICENTER STUDY; POLYP; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; VERY ELDERLY; YOUNG ADULT; ADENOCARCINOMA; ADOLESCENT; CASE CONTROL STUDY; CHRONIC DISEASE; CLINICAL TRIAL; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; COMPLICATION; ENDOSCOPY; FOLLOW UP; IMMUNOHISTOCHEMISTRY; PATHOLOGY; PROGNOSIS; RISK FACTOR;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CASE-CONTROL STUDIES; CHRONIC DISEASE; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; COLITIS, MICROSCOPIC; COLONOSCOPY; COLORECTAL NEOPLASMS; DIARRHEA; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84902155430     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000030     Document Type: Article

References (55)

1. Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology. 2011;140: 1155-1165.
2. Münch A, Aust D, Bohr J, et al. Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis. 2012;6:932-945.
3. Sonnenberg A, Genta RM. Lymphocytic and collagenous colitis: epidemiologic differences and similarities. Dig Dis Sci. 2013;58:2970-2975.
4. Vigren L, Olesen M, Benoni C, et al. Are collagenous and lymphocytic colitis different aspects of the same disease? Scand J Gastroenterol. 2012; 47:1448-1453.
5. Rasmussen MA, Munck LK. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease-microscopic colitis? Aliment Pharmacol Ther. 2012;36:79-90.
6. Chetty R, Govender D. Lymphocytic and collagenous colitis: an overview of so-called microscopic colitis. Nat Rev Gastroenterol Hepatol. 2012;9: 209-218.
7. Pardi DS, Loftus EV Jr, Smyrk TC, et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut. 2007;56:504-508.
8. Olesen M, Eriksson S, Bohr J, et al. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut. 2004;53:346-350.
9. Fernández-Bañares F, Salas A, Esteve M, et al. Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a populationbased study. In flamm Bowel Dis. 2011;17:1015-1020.
10. Nielsen OH, Vainer B, Schaffalitzky de Muckadell OB. Microscopic colitis: a missed diagnosis? Lancet. 2004;364:2055-2077.
11. Logan RFA. Problems and pitfalls in epidemiological studies of celiac disease. Din Nutr Res. 1992;2:14-24.
12. Beaugerie L, Pardi DS. Review article: drug-induced microscopic colitis -proposal for a scoring system and review of the literature. Aliment Pharmacol Ther. 2005;22:277-284.
13. Fernández-Bañares F, Esteve M, Espinos JC, et al. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol. 2007;102:324-330.
14. Fernández-Bañares F, de Sousa MR, Salas A, et al. Epidemiological risk factors in microscopic colitis: a prospective case-control study. In flamm Bowel Dis. 2013;19:411-417.
15. Vigren L, Sjöberg K, Benoni C, et al. Is smoking a risk factor for collagenous colitis? Scand J Gastroenterol. 2011;46:1334-1339.
16. Fernández-Bañares F, de Sousa MR, Salas A, et al. Impact of current smoking on the clinical course of microscopic colitis. In flamm Bowel Dis. 2013;19:1470-1476.
17. Yen EF, Pokhrel B, Du H, et al. Current and past cigarette smoking significantly increase risk for microscopic colitis. In flamm Bowel Dis. 2012;18:1835-1841.
18. Guagnozzi D, Lucendo AJ, Angueira-Lapeña T, et al. Prevalence and incidence of microscopic colitis in patients with diarrhoea of unknown aetiology in a region in central Spain. Dig Liver Dis. 2012;44:384-388.
19. Thörn M, Sjöberg D, Ekbom A, et al. Microscopic colitis in Uppsala health region, a population-based prospective study 2005-2009. Scand J Gastroenterol. 2013;48:825-830.
20. Bohr J, Tysk C, Eriksson S, et al. Collagenous colitis in Orebro, Sweden, an epidemiological study 1984-1993. Gut. 1995;37:394-397.
21. Fernández-Bañares F, Salas A, Forne M, et al. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol. 1999;94:418-423.
22. Williams JJ, Kaplan GG, Makhija S, et al. Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol. 2008;6:35-40.
23. Kao KT, Pedraza BA, McClune AC, et al. Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol. 2009;15:3122-3127.
24. Vigren L, Olesen M, Benoni C, et al. An epidemiological study of collagenous colitis in southern Sweden from 2001-2010. World J Gastroenterol. 2012;18:2821-2826.
25. Olesen M, Eriksson S, Bohr J, et al. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut. 2004;53:536-541.
26. Fine KD, Seidel RH, Do K. The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endosc. 2000;51:318-326.
27. Shah RJ, Fenoglio-Preiser C, Bleau BL, et al. Usefulness of colonoscopy with biopsy in the evaluation of patients with chronic diarrhea. Am J Gastroenterol. 2001;96:1091-1095.
28. Schusselé Filliettaz S, Juillerat P, Burnand B, et al. Appropriateness of colonoscopy in Europe (EPAGE II). Chronic diarrhea and known inflammatory bowel disease. Endoscopy. 2009;41:218-226.
29. Hotouras A, Collins P, Speake W, et al. Diagnostic yield and economic implications of endoscopic colonic biopsies in patients with chronic diarrhoea. Colorectal Dis. 2012;14:985-988.
30. Yen EF, Pokhrel B, Bianchi LK, et al. Decreased colorectal cancer and adenoma risk in patients with microscopic colitis. Dig Dis Sci. 2012;57: 161-169.
31. Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology. 1999;116:1464-1486.
32. Thomas PD, Forbes A, Green J, et al. Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut. 2003;52:v1-v15.
33. Lai EJ, Calderwood AH, Doros G, et al. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc. 2009;69(3 pt 2):620-625.
34. Villanacci V, Casella G, Bassotti G. The spectrum of drug-related colitides: important entities, though frequently overlooked. Dig Liver Dis. 2011;43:523-528.
35. ASGE Standards of Practice Committee, Shen B, Khan K, et al. The role of endoscopy in the management of patients with diarrhea. Gastrointest Endosc. 2010;71:887-892.
36. Dignass A, Eliakim R, Magro F, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6:965-990.
37. Van Assche G, Dignass A, Panes J, et al. The second European evidencebased consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis. 2010;4:7-27.
38. Magro F, Langner C, Driessen A, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 2013;7: 827-851.
39. Lambert R, Kudo SE, Vieth M, et al. Pragmatic classification of superficial neoplastic colorectal lesions. Gastrointest Endosc. 2009;70: 1182-1199.
40. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58:S3-S43.
41. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50: 113-130.
42. Agnarsdottir M, Gunnlaugsson O, Orvar KB, et al. Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci. 2002;47:1122-1128.
43. Storr MA. Microscopic colitis: epidemiology, pathophysiology, diagnosis and current management-an update 2013. ISRN Gastroenterol. 2013; 2013:352718.
44. Zins BJ, Sandborn WJ, Tremaine WJ. Collagenous and lymphocytic colitis: subject review and therapeutic alternatives. Am J Gastroenterol. 1995; 90:1394-1400.
45. Valle Mansilla JL, León Barúa R, Recavarren Arce S, et al. Microscopic colitis in patients with chronic diarrhea. Rev Gastroenterol Peru. 2002;22: 275-278.
46. Essid M, Kallel S, Ben Brahim E, et al. Prevalence of the microscopic colitis to the course of the chronic diarrhea: about 150 cases [in French]. Tunis Med. 2005;83:284-287.
47. Gado AS, Ebeid BA, El Hindawi AA, et al. Prevalence of microscopic colitis in patients with chronic diarrhea in Egypt: a single-center study. Saudi J Gastroenterol. 2011;17:383-386.
48. Park YS, Baek DH, Kim WH, et al. Clinical characteristics of microscopic colitis in Korea: prospective Multicenter Study by KASID. Gut Liver. 2011;5:181-186.
49. Gu HX, Zhi FC, Huang Y, et al. Microscopic colitis in patients with chronic diarrhea and normal colonoscopic findings in Southern China. Int J Colorectal Dis. 2012;27:1167-1173.
50. Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10:639-645.
51. Jess T, Gamborg M, Matzen P, et al. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724-2729.
52. Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008;454:436-444.
53. Rizzo A, Pallone F, Monteleone G, et al. Intestinal inflammation and colorectal cancer: a double-edged sword? World J Gastroenterol. 2011; 17:3092-3100.
54. Nickoloff BJ, Ben-Neriah Y, Pikarsky E. Inflammation and cancer: is the link as simple as we think? J Invest Dermatol. 2005;124:10-14.
55. Andresen L, Jørgensen VL, Perner A, et al. Activation of nuclear factor kappa B in colonic mucosa from patients with collagenous and ulcerative colitis. Gut. 2005;54:503-509.